Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Aaron Sato

Showing results (1-10 of 6) with videos related to

Pageof 1
Sort By:
Nuclear Medicine and Biology|January 12, 2002
Nitriles form mixed-coligand complexes with (99m)Tc-HYNIC-peptideGuozheng Liu, Charles Wescott, Aaron Sato, et al.
Journal of Clinical Periodontology|December 23, 2018
Immunization with cell-free-generated vaccine protects from Porphyromonas gingivalis-induced alveolar bone lossNasi Huang, Elyse Shimomura, Gang Yin, et al.
Cell Stem Cell|August 12, 2009
DLL4 blockade inhibits tumor growth and reduces tumor-initiating cell frequencyTimothy Hoey, Wan-Ching Yen, Fumiko Axelrod, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 3, 2015
Targeting Notch signaling with a Notch2/Notch3 antagonist (tarextumab) inhibits tumor growth and decreases tumor-initiating cell frequencyWan-Ching Yen, Marcus M Fischer, Fumiko Axelrod, et al.
Oncogene|May 20, 2025
A multi-faceted discovery strategy identifies functional antibodies binding to cysteine-rich domain 1 of hDKK1 for cancer immunotherapy via Wnt non-canonical pathwayLinya Wang, Sean M Peterson, Marisa Yang, et al.
Proceedings of the National Academy of Sciences of the United States of America|July 4, 2012
Wnt pathway inhibition via the targeting of Frizzled receptors results in decreased growth and tumorigenicity of human tumorsAustin Gurney, Fumiko Axelrod, Christopher J Bond, et al.
Pageof 1

Showing results (1-10 of 6) with videos related to

Sort By:
Pageof 1
Nuclear Medicine and Biology|January 12, 2002
Nitriles form mixed-coligand complexes with (99m)Tc-HYNIC-peptideGuozheng Liu, Charles Wescott, Aaron Sato, et al.
Journal of Clinical Periodontology|December 23, 2018
Immunization with cell-free-generated vaccine protects from Porphyromonas gingivalis-induced alveolar bone lossNasi Huang, Elyse Shimomura, Gang Yin, et al.
Cell Stem Cell|August 12, 2009
DLL4 blockade inhibits tumor growth and reduces tumor-initiating cell frequencyTimothy Hoey, Wan-Ching Yen, Fumiko Axelrod, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 3, 2015
Targeting Notch signaling with a Notch2/Notch3 antagonist (tarextumab) inhibits tumor growth and decreases tumor-initiating cell frequencyWan-Ching Yen, Marcus M Fischer, Fumiko Axelrod, et al.
Oncogene|May 20, 2025
A multi-faceted discovery strategy identifies functional antibodies binding to cysteine-rich domain 1 of hDKK1 for cancer immunotherapy via Wnt non-canonical pathwayLinya Wang, Sean M Peterson, Marisa Yang, et al.
Proceedings of the National Academy of Sciences of the United States of America|July 4, 2012
Wnt pathway inhibition via the targeting of Frizzled receptors results in decreased growth and tumorigenicity of human tumorsAustin Gurney, Fumiko Axelrod, Christopher J Bond, et al.
Pageof 1